Allergan plc
AGN.PRA
AGN.PRA was delisted on the 28th of February, 2018.
106 hedge funds and large institutions have $2.81B invested in Allergan plc in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 16 closing their positions.
46% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 28
3% less funds holding
Funds holding: 109 → 106 (-3)
11% less capital invested
Capital invested by funds: $3.17B → $2.81B (-$355M)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$89.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$58.5M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$49.6M |
| 4 |
SG Americas Securities
New York
|
+$42.4M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$36.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$68M |
| 2 |
WAMC
Western Asset Management Company
Pasadena,
California
|
-$44.9M |
| 3 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
-$37.4M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$19.7M |
| 5 |
QF
QVT Financial
New York
|
-$17.4M |
AGN.PRA Hedge Fund Activity: Q3 2017 in Review
106 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q3 2017, worth a combined $2.81B — down 11% from $3.17B a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of AGN.PRA and 13 opened new positions — a net loss of 3 holders — while 28 trimmed existing stakes and 41 added.
The largest buyer was PFM Health Sciences, opening a new position worth an estimated $89.2M. The largest seller was Weiss Asset Management, exiting entirely with an estimated $68M sold.
- 106 institutional investors held Allergan plc (AGN.PRA) as of Q3 2017, down from 109 in Q2 2017.
- Funds reported $2.81B of Allergan plc stock for Q3 2017, down 11% quarter-over-quarter.
- 13 funds opened new Allergan plc positions in Q3 2017 and 16 closed out, a net change of -3 holders.
- The largest Allergan plc buyer in Q3 2017 was PFM Health Sciences, an estimated $89.2M added.
- The largest Allergan plc seller in Q3 2017 was Weiss Asset Management, an estimated $68M sold.
Based on aggregated 13F filings for Q3 2017.